Mesenchymal Stem/Stromal Cells: HUMAN MESENCHYMAL STEM CELL THERAPY IN SEVERE COVID-19 PATIENTS: 2-YEAR FOLLOW-UP RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

Detalles Bibliográficos
Autores principales: Li, T., Yao, W., Zhang, B., Fang, H., Shi, M., Zhang, Y., Li, Y., Wang, Z., Zhang, Z., Yuan, M., Dong, T., Xie, W., Shi, L., Wang, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society for Cell & Gene Therapy. Published by Elsevier Inc. 2023
Materias:
Late Breaking Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171025/
http://dx.doi.org/10.1016/S1465-3249(23)00706-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171025/
http://dx.doi.org/10.1016/S1465-3249(23)00706-5

Ejemplares similares